e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Systemic effects of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vastus lateralis muscle anabolic and inflammatory marker expression in patients with acute COPD exacerbations (AE)
T. Crul, M. A. Spruit, G. Gayan-Ramirez, R. Quarck, R. Gosselink, T. Troosters, F. Pitta, A. Kasran, M. Decramer (Leuven, Belgium)
Source:
Annual Congress 2005 - Systemic effects of COPD
Session:
Systemic effects of COPD
Session type:
Oral Presentation
Number:
4202
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Crul, M. A. Spruit, G. Gayan-Ramirez, R. Quarck, R. Gosselink, T. Troosters, F. Pitta, A. Kasran, M. Decramer (Leuven, Belgium). Vastus lateralis muscle anabolic and inflammatory marker expression in patients with acute COPD exacerbations (AE). Eur Respir J 2005; 26: Suppl. 49, 4202
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Microarray gene profiling of
vastus lateralis
muscle in COPD patients with an acute exacerbation
Source: Eur Respir J 2007; 30: Suppl. 51, 533s
Year: 2007
Microarray gene expression profiling in
vastus lateralis
muscle during an acute COPD exacerbation suggest increased inflammation and apoptosis
Source: Eur Respir J 2006; 28: Suppl. 50, 584s
Year: 2006
Vastus lateralis proteomic analysis in muscle wasted patients with COPD
Source: Annual Congress 2013 –The best abstracts in physical inactivity and exercise training in COPD
Year: 2013
Severe COPD patients exhibit increased muscle proteolysis in their vastus lateralis
Source: Annual Congress 2010 - Interaction between respiratory and peripheral muscles
Year: 2010
Apoptosis in vastus lateralis muscle of patients with COPD
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD
Source: Eur Respir J 2004; 24: 971-979
Year: 2004
Myopathologic features in the vastus lateralis of patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 88s
Year: 2002
Is systemic inflammation the main driver of skeletal muscle weakness during COPD exacerbations (AE)?
Source: Eur Respir J 2005; 26: Suppl. 49, 180s
Year: 2005
In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD
Source: Eur Respir J 2003; 21: 273-278
Year: 2003
Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD
Source: Eur Respir J 2007; 30: 73-79
Year: 2007
Quadriceps force and survival after hopsitalisation due to an acute exacerbation in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 662s
Year: 2004
Analysis of different equations to predict quadriceps femoris muscle strength in patients with COPD
Source: International Congress 2015 – Respiratory physiotherapy assessment and techniques in COPD and asthma
Year: 2015
Quadriceps wasting and physical inactivity in patients with COPD
Source: Eur Respir J 2012; 40: 1115-1122
Year: 2012
Skeletal muscle inflammatory markers in COPD patients with muscle wasting
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Structural changes in vastus lateralis and contractile leg fatigue in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 217s
Year: 2004
Vitamin D receptor genotypes influence quadriceps strength in COPD
Source: Annual Congress 2007 - Pathophysiology of respiratory muscles
Year: 2007
The estimation of respiratory muscles (RM) status by echodensitometry in male patients with acute exacerbation of COPD (AECOPD)
Source: Annual Congress 2010 - Interaction between respiratory and peripheral muscles
Year: 2010
Inspiratory muscle weakness in mildly- to moderately-hyperinflated patients with COPD
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in COPD and asthma
Year: 2014
Evaluation of quadriceps muscle function in patients with moderate to severe COPD
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
Reduced mitochondrial density in the vastus lateralis muscle of COPD patients with low fat free mass
Source: Annual Congress 2012 - The best abstracts in pulmonary rehabilitation
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept